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Silent information regulator-1 (SIRT1) deacetylase, a sensor of intermittent energy
restriction, is inextricably intertwined with circadian regulation of central and peripheral
clock genes. The purpose of this study was to identify SIRT1-specific target genes that
are expressed in a circadian rhythm pattern and driven, in part, by specific components
of foodstuffs. Using human cells and rats fed with a resveratrol diet we show that
SIRT1 binds to, and transcriptionally regulates, a gene locus encoding the G protein-
coupled receptor (GPR), GPR50 in the brain. GPR50 is the mammalian orthologue
of the melatonin1c membrane-bound receptor which has been identified as a genetic
risk factor for bipolar disorder and major depression in women. In general, our findings
support and expand the notion that circadian clock signaling components and dietary
interventions are adaptively linked, and suggest that the brain may be particularly
sensitive to metabolic events in response to light-dark cycles.
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INTRODUCTION
Our physiology is driven by internal timing systems known as circadian clocks. Disruption of
the clock contributes to the pathophysiology of several psychiatry disorders, including seasonal
affective disorder, major depressive disorder, bipolar disorder and schizophrenia (Radeljak et al.,
2008; Boyce and Barriball, 2010; Westrich and Sprouse, 2010). However, it is not clear whether
disruption of rhythmic physiology per se, or altered functioning of individual clock components
drives pathology. Nevertheless, the human silent information regulator-1 analog (SIRT1) appears
to play a significant role in the clock-interdependent signaling mechanisms as SIRT1 modifies
the feedback loop expression of circadian proteins, such as BMAL1 and PER2 (Asher et al., 2008;
Nakahata et al., 2008, 2009; Ramsey et al., 2009). These findings suggest that rhythmic regulation of
clock proteins is mediated by post-translational modifications driven, in part, by metabolic sensors
such as SIRT1.
In this article, we report that the G protein-coupled receptor 50 (GPR50; Reppert et al., 1996)
is a SIRT1-specific DNA target as demonstrated in human and rodent cells. GPR50 represents
the mammalian orthologue of the vertebrate receptor MEL1c (Dufourny et al., 2008) and shares
biochemical similarity with the two known melatonin receptors, MT1 and MT2. Despite structural
similarities and the ability to dimerize with MT1 and MT2 receptors (Levoye et al., 2006), GPR50
does not bind melatonin and it is therefore classified as an orphan receptor with unknown
endogenous or synthetic ligand(s). The hormone melatonin is secreted by the pineal gland
and functions in the regulation of neural and endocrine processes, including readjusting the
circadian pacemaker, the suprachiasmatic nucleus of the hypothalamus (SCN), to photo-period
signals (Torres et al., 1989). To receive and relay melatonin photo-periodic transmission codes to
appropriate neural networks, MT1 and MT2 must assemble into functional homo- or heterodimer
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(e.g., MT1/MT1; MT1/MT2; MT2/MT2) configurations within
the bilayer lipidmembrane to initiate secondmessenger cascades.
For instance, whereas endogenous GPR50/MT2 heterodimers are
melatonin responsive, MT1/GPR50 heterodimers are relatively
silent to periodic depolarization pulses from pinealocytes
(Levoye et al., 2006). The spatiotemporal diversity of these
interactions highlights the wide range of GPR50-mediated
responses to extracellular signaling events, which in turn
converge on processes regulating gene transcription and the
synthesis of proteins by local ribosomes.
To test the hypothesis that GPR50 is a DNA target directly
affected by SIRT1, in vivo assays in conjunction with in vitro
experiments were used to accomplish this experimental goal.
More specifically, we used a previously described ChIP-cloning
chromatin immunoprecipitation cell assay which links SIRT1
to transcriptional modification of certain endogenous DNA
targets (Torres et al., 2008). For the in vivo experiments, we
fed rats with trans-resveratrol (trans-3,5,4′-trihydroxystilbene)
which is one of the signaling cues that activate SIRT1
transcription in the mammalian brain (Baur and Sinclair, 2006;
Torres et al., 2011). Our results identify a new SIRT1 DNA
target and highlight the significance of the trans-membrane
GPR50 receptor in metazoan circadian rhythms and metabolic
status.
MATERIALS AND METHODS
Culture, Treatment, and Collection
of Human Cells
Adherent human embryonic kidney cells (HEK-293; CRL-1573;
ATCC, VA, USA) and a mixture of floating and adherent
human neuroblastoma cells (SH-SY5Y; CRL-2266; ATCC,
Manassas, VA, USA) were grown under standard culture
conditions at 37◦C in a humidified atmosphere with 5% CO2 on
75 mm2–100 mm2 or multiwell cell culture dishes (6–24 well).
As base medium for HEK-293 cells we used Dulbecco’s Modified
Eagle Medium (DMEM) whereas the base for SH-SY5Y was a
1:1 mixture of Eagle’s Minimum Essential Medium (EMEM)
and F12 medium (Invitrogen/Life Technologies, Carlsbad,
CA, USA). For induction and maintenance of a dopamine
neuronal phenotype, SH-SY5Y cells were supplemented
with 1 µM all trans-retinoic acid (Sigma-Aldrich, St. Louis,
MO, USA) throughout the experiment. Immediately before
use, supplements (Invitrogen/Life Technologies, Carlsbad,
CA, USA) were added to the following reagents to yield
their final concentrations of: 10% fetal bovine serum, 1%,
penicillin/streptomycin, 1% non-essential amino acids,
1% stabile glutamine (Glutamax), and 1% anti-mycotic
(Fungizone). At a culture density of approximately 70%,
cells were subcultured 1:10 using 0.25% (w/v) Trypsin/0.53 mM
EDTA. All cell treatments were initiated at a cellular confluence
of approximately 70%. Resveratrol was dissolved in DMSO
at a concentration of 100 mM and stored in aliquots at
−20◦C in a light-proof container. Resveratrol was used at
a final concentration of 50 µM in growth media for 48 h.
Leptomycin B (in DMSO) was used at a final concentration
of 10 nM in growth media for 3 h. At the end of a treatment
period, cells were washed with PBS, scraped off, collected by
centrifugation and either directly used or flash frozen and stored
at−80◦C.
Animals, Dietary Supplementation and
Tissue Collection
All animal experiments were conducted in compliance with
the Institutional Animal Care and Use Committee (IACUC)
guidelines. Sexually-mature male Sprague-Dawley rats (Charles
River, Wilmington, MA, USA) were housed in groups of
three rats per cage under a strict 12 h light-dark cycle. The
experimental animal group (n = 11) received dietary resveratrol
mixed into a purified phytoestrogen-free AIN-76A basis diet
(Harlan Teklad, Madison, WI, USA) provided ad libitum
together with tap water for 28 consecutive days. Animals in
the control group (n = 11) were fed the same dietary mixture
without resveratrol. Animal weight and food consumption were
recorded daily. On experimental day 29, animals were sacrificed
by decapitation; whole trunk blood collected and allowed to
clot for 2 h at room temperature. Serum was then separated by
centrifugation (1800 g, 10 min) and stored frozen at−80◦C until
assayed. For gene expression and western blot analysis, rat brains
were cut longitudinally into equal halves, flash frozen on dry ice
and stored at−80◦C.
Determination of Serum Resveratrol Levels
Samples were hydrolyzed with beta-glucuronidase and extracted
with ethyl acetate. The extracts were reconstituted in 5 mM
ammonium acetate, pH 8.1: Methanol (50:50) and washed with
hexane. The internal standard used was bis-(4-hydroxyphenyl)-
methane. Due to concerns about the stability of resveratrol, the
analysis preparation was performed in reduced room light and
the extract evaporation used nitrogen instead of air. The extracts
were analyzed by Liquid Chromatography–Mass Spectrometry
using negative ion electrospray ionization (University of Utah,
Center for Human Toxicology, Salt Lake City, UT, USA). The
lower resolution level was set at10 ng/ml.
Western Blot Analysis of Human Cells and
Rat Brain Tissue
Rat brain halves or cell pellets were thawed on ice, pre-
homogenized with sterile pestle and tubes (Kimble-Kontes,
Vineland, NJ, USA). 30 µl of a pre-homogenate were mixed
with 300 µl of radio immuno precipitation assay (RIPA) buffer
for whole cell lysis [0.05 M Tris–HCl, pH 8.0, 1% NP-40,
0.5% deoxycholate, 0.1% SDS, protease inhibitor cocktail 1:500
(Sigma, Saint Louis, MO, USA)] and treated with an electric
homogenizer followed by two blade rinses with RIPA buffer
(100 µl each). Lysates were maintained under constant agitation
(orbital shaker) for another 2 h at 4◦C before centrifugation
(20,000 g, 20 min at 4◦C). Supernatants were assayed for protein
concentration and stored in aliquots at −80◦C. Upon thawing,
samples were mixed with 2 × SDS-PAGE loading dye plus
100 mM DTT and heated to 95◦C for 5 min for denaturation.
Protein electrophoresis was carried out at equal protein
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loading (5 mg/ml) on 4–15% denaturing SDS-polyacrylamide
gradient gels. Proteins were transferred onto nitrocellulose
in a wet chamber (125 mA/gel, 90 min). Membranes were
cut according to protein standards and probed 1:500 with
either one of the following primary antibodies: polyclonal
rabbit anti-human SIRT1 (Bethyl Laboratories, Montgomery,
TX, USA); polyclonal rabbit anti-actin (H-300; Santa Cruz
Biotechnology, Santa Cruz, CA, USA). For visualization, an
appropriate horseradish peroxidase-coupled secondary antibody
and color reaction were used according to the manufacturer
(Thermo Fisher Scientific, Rockford, IL, USA). Results were
recorded on a western-blot imaging system and exported into
Adobe Photoshop CS6 (Adobe Systems Incorporated, Mountain
View, CA, USA).
Quantitative PCR (QPCR) on Human Cells
and Rat Brain
For the in vitro determination of resveratrol-dependent changes
in sirt1 and gpr50 expression (n ≥ 40), HEK-293 cells were
grown and treated onmulti-well dishes (6-well) and subsequently
collected as described above. Total RNA was prepared separately
from each well using the RNeasy RNA-isolation system in
combination with QIA shredder columns according to the
manufacturer’s specifications (Qiagen, Valencia, CA, USA). To
determine the effect of dietary resveratrol on the expression of
sirt1 and gpr50 in the brain, rat brain halves were pulverized
with pestle, mortar and liquid nitrogen. Total RNA was prepared
from 30 mg tissue samples representing the entire brain
as delineated above. RNA concentration and integrity were
determined with standard spectrophotometry and agarose gel-
electrophoresis. Reverse transcription RT-PCR was performed
using the Superscript III First-Strand Synthesis System for
RT-PCR (Invitrogen/Life Technologies, Carlsbad, CA, USA).
QPCR was carried out with the Power SYBR Green PCR
Master Mix (Applied Biosystems, Foster City, CA, USA). DNA
Primers were designed using the Integrated DNA Technologies
PrimerQuest tool (IDT, Coralville, IA, USA). DNA primers
used with human cells: sirt1 forward: 5′-CTG TAG ACT TCC
CAG ATC TTC CAG-3′; sirt1 reverse: 5′-GTG ACA GAG
AGA TGG CTG GAA TTG -3′; β-actin forward: 5′-CAG CCA
TGT ACG TTG CTA TCC AGG-3′; β-actin reverse: 5′-AGG
TCC AGA CGC AGG ATG GCA TG -3′; gpr50 forward: 5′-
CTT TGA TGC TGC ATG CCA TGT CCA-3′; gpr50 reverse:
5′-TGT GGC AGA TGT AGC AGT AAC GGT-3′. DNA
primers used with rat brain tissue: sirt1 forward: 5′-ACA ACC
TCC TGT TGG CTG ATG AGA -3′; sirt1 reverse: 5′-AGA
ATT GTT CGA GGA TCG GTG CCA-3′; β-actin forward:
5′-TGA GAG GGA AAT CGT GCG TGA CAT-3′; β-actin
reverse: 5′-ACC GCT CAT TGC CGA TAG TGA TGA-3′;
gpr50 forward: 5′-AAA GGA AAT GGC AGG CAA GAT
CCC-3′; gpr50 reverse: 5′-ATG AAC AGG ATA GGG TGC
CGC ATA-3′.
ChIP of SIRT1 DNA Targets
For each experiment HEK-293 cells from 10 fully confluent
100 mm2 culture dishes were grown to 90–100% confluence.
The EZ ChIP Kit (Upstate Technologies/EMD Millipore,
Temecula, CA, USA) was used according to the manufacturer’s
specifications for the generation and purification of SIRT1
specific genomic DNA. Briefly, after generating DNA/protein
complexes through formaldehyde treatment of the cells, DNA
was sheared by sonication of the cell lysate on wet ice into
approximately 200–1000 base pair (bp) fragments (5 × 10 s
pulses, 30% maximum power, 2 mm tip; Cell Disruptor,
Heat-Systems Ultrasonics, Plainview, NY, USA). SIRT1/DNA
complexes were immunoprecipitated with either 10 µg of a
monoclonal (MC; Clone 2G1/F7, Upstate Technologies/EMD
Millipore, Temecula, CA, USA) or a polyclonal antibody
with human SIRT1 specificity (PC; Bethyl Laboratories,
Montgomery, TX, USA). Standard rabbit Immunoglobulin G
antibody (IgG) was used to generate the negative controls and
a polyclonal rabbit antibody specific to acetylated histone
H3 (AcH3) served to obtain positive controls (Upstate
Technologies/EMD Millipore, Temecula, CA, USA). A sample
of the initially cross-linked protein/DNA complexes was saved
as input (IP).
Cloning of SIRT1-Specific DNA Targets
Aliquots of 5 µl of the purified DNA solution obtained
with monoclonal anti-SIRT1 antibody were treated with
T4 DNA polymerase and dNTPs (Roche Applied Science,
Mannheim, Germany) for 15 min at 16◦C and subsequently
heat inactivated at 75◦C for 10 min. According to the
manufacturer’s instructions, EcoRI adaptor oligonucleotides
were ligated to the DNA pieces and excess adaptors subsequently
removed with Sephacryl S-400 spin columns (Universal
Riboclone cDNA Synthesis System, Promega, Madison,
WI, USA). Purified DNA was amplified by standard PCR,
using primer matching the EcoRI adaptor sequence (forward
and reverse primer: AATTCCGTTGCTGTCG). Amplified
DNA was briefly separated on 1.5% agarose gels from which
a fragment range between approximately 200 bp–500bp
was extracted (Qiagen, Valencia, CA, USA). Purified DNA
was ligated into the pGEM-T Easy vector system and
transformed into E. coli JM109 (Promega, Madison, WI,
USA).
Identification and Analysis of SIRT-Specific
DNA Targets
Plasmid DNA from positive transformants (beta-galactosidase
negative) was treated with EcoRI restriction endonuclease
and analyzed by standard agarose gels electrophoresis (1.5%)
to confirm presence of an insert. Confirmed clones were
selected for DNA sequencing using standard T7 sequencing
primer (T7 RNA polymerase promoter). DNA sequences were
analyzed with the ‘‘Basic Local Alignment Search Tool’’ (BLAST;
www.ncbi.nlm.nih.gov/blast/).
Verification of SIRT1 Binding to the GPR50
Locus
GPR50-specific DNA-primers (forward: ACTACA
GTAGGGTCAGGAAGGTCA; reverse: TAAACCCACCAC
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TGGCCACATCAA; IDT, Coralville, IA, USA) were used
together with a high-sensitivity PCR protocol (Soriano et al.,
1991) on unamplified ChIP DNA obtained with both anti-SIRT1
antibodies. Gene-specific amplicons and proper controls were
analyzed by analytical agarose gel electrophoresis (1.5%).
Determination of Melatonin-Dependent
Phospholipase C (PLC) Activity with ELISA
SH-SY5Y cells were grown to 70% density on 24-well plates
before treatment. For a knockdown of SIRT1, cells were
transfected with morpholino oligonucleotides (Gene Tools LLC,
Philomath, OR, USA) for 4 h in serum-free medium with
Lipofectamine 2000 (Invitrogen/Life Technologies, Carlsbad,
CA, USA). At the same time, all non-transfected cells were
treated with same serum-free medium and the transfection
reagent without oligonucleotides to control for methodology-
related variability. Anti-human SIRT1 and oligo-N random
oligonucleotide control morpholinos (CMO) were applied at
100 pmol. Resveratrol was used for 48 h at 50 µM; melatonin
was used for 48 h at 100 nM; luzindole was used for 48 h
at 100 µM; the absolute control was treated with the solvent
(DMSO) alone. Cells were washed twice with PBS, scraped
off their well, collected by centrifugation and re-suspended
in 130 µl PLC reaction buffer (Invitrogen/Life Technologies,
Carlsbad, CA, USA) containing a protease inhibitor cocktail
1:500 (Sigma-Aldrich, St. Louis, MO, USA). Cells were lysed
on ice by brief sonication for 3 s at maximum output control
setting 3 (Cell Disruptor, Heat-Systems Ultrasonics, Plainview,
NY, USA). Cell lysates were spun at 14,000 g for 5 min
and 100 µl of each supernatant transferred to a pre-chilled
96-well microtiter plate. PLC activity was determined using
the EnzChek Direct Phospholipase C Assay Kit according to
the manufacturer’s specifications (Invitrogen/Life Technologies,
Carlsbad, CA, USA). Fluorescence was measured with a standard
ELISA reader at 2, 4, 18, 24, and 48 h (485/20, 528/20). The
presented values were determined at 18 h and are representative
for the entire experiment. Data are presented as themean± SEM.
p < 0.05 by Student’s t test(s) were used for comparison with
control (∗); n = 12.
RESULTS
SIRT1 Associates with the Gene Encoding
the Orphan Receptor GPR50
To identify specific genes that are transcriptionally regulated
by SIRT1, we subjected HEK-293 cells to a ChIP assay
with two unrelated anti-SIRT1 antibodies. Sequencing of the
immunoprecipitated DNA identified a 300 bp genomic sequence
overlapping most of the 3′ exon of gpr50 and its downstream,
non-coding region as a SIRT1 DNA target. To verify the presence
of SIRT1 on this target locus, we used unamplified ChIP DNA
in a PCR reaction with DNA primers matching the 3′ region
of genomic gpr50 (Figure 1). Both SIRT1-specific antibodies
yielded identical results, thus supporting our initial findings.
FIGURE 1 | Human gpr50 is a SIRT1 DNA target. DNA gel electrophoresis
is shown of PCR amplicon on unamplified ChIP DNA with DNA primers
matching genomic gpr50 at its most 3′exon and downstream non-coding
region. The size of this amplicon is about 300 bp. Standard Taq-PCR was
performed on the samples indicated. Two independent SIRT1 antibodies were
used (lanes 4 and 5).
Resveratrol Treatment Increases gpr50
Expression through SIRT1 in HEK-293
Cells
To study the effect of resveratrol on the expression of sirt1
and its gene target, gpr50 (n = 20 for all experiments),
we compared the transcription activity of both genes with
and without resveratrol (Figure 2A). Resveratrol treatment
(50 µM) of HEK-293 cells for 48 h caused a significant
transcriptional increase of sirt1 of 1.9 fold (p = 8.1 × 10–6)
along with an average increase of gpr50 transcription of 5.6
fold (p = 7.8 × 10–11) plus a notable increase in SIRT1 protein
levels (Figure 2A). To demonstrate SIRT1 dependence of the
observed gpr50 transcriptional increase in HEK-293 cells, we
administered previously tested (Torres et al., 2011) morpholino
oligonucleotides (morpholinos) with or without resveratrol.
Application of a sirt1-specific morpholino reduced native- as
well as resveratrol-enhanced sirt1 transcription significantly by
about 60% (p = 2.4 × 10–2) and 70% (p = 8 × 10–3) respectively,
whereas the application of a standard control morpholino mix
showed no considerable effect (p = 0.61). These findings are in
agreement with SIRT1 protein levels as shown in (Figure 2B).
Using HEK-293 cells, we further found that application of sirt1-
specific morpholino significantly reduced resveratrol-dependent
gpr50 transcript levels from 5.6-fold to about 1.6 fold (p = 1.7 ×
10–6), whereas cellular transfection with CMO did not exert any
significant effect at all (p = 0.46; Figure 2C).
Dietary Resveratrol Increases gpr50
Expression in Rat Brain
To address the effects of dietary resveratrol on the expression of
sirt1 and gpr50 in the mammalian brain, we analyzed whole brain
tissue from rats exposed to a 4-week resveratrol diet regiment.
Average serum levels of resveratrol were found to be 349.2
± 97 ng/ml in the experimental group, but predictably absent
in the control group. Whereas transcription of sirt1 (QPCR)
and protein levels (western-blot) were indistinguishable between
experimental and control rats (data not shown), we found that
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FIGURE 2 | Knockdown of SIRT1 reverses resveratrol effects on gpr50
expression in HEK-293 cells. (A) Quantitative PCR (QPCR) analysis of
resveratrol-induced (50 µM; 48 h) transcriptional changes compared to
vehicle only (DMSO). Resveratrol treatment induces significant transcriptional
increases in sirt1 (1.9 fold) and gpr50 (5.6 fold). Western-blot analysis supports
resveratrol-dependent stimulation of SIRT1 protein levels (inset) (B) QPCR and
western blot validation of sirt1 morpholino knockdown from basal levels
(columns1–3) and after resveratrol induction (columns 4–6). Values are means
± SD. ∗ Indicates statistical significance of annotated p; n = 20. (C) Morpholino
oligonucleotide knockdown of sirt1 reverses resveratrol-induced gpr50
transcriptional increases [5.6 fold→ 1.6 fold (columns 2 and 4)]. The inclusion
of a standard control morpholino mix has no significant effect (column 3).
gpr50 transcription was significantly up-regulated by 4.5 fold
(p = 2.2× 10–3) in the resveratrol-fed group (Figure 3).
PLC Activity and gpr50 Transcription are
Reversibly Linked in Neurons with a
Dopamine Phenotype
HEK-293 cells subjected to melatonin treatment did not yield
reproducible changes in PLC activity (data not shown) and were
therefore excluded from this assay. Encouraged by our findings in
FIGURE 3 | Dietary resveratrol stimulates gpr50 transcription in rat
brain. Analysis of whole brain extracts of animals fed resveratrol (1 g/kg chow;
4 weeks) shows a significant increase in gpr50 transcription of 4.5 fold. Values
are means ± SEM. ∗ indicates statistical significance of annotated p; n = 11
animals per group.
rat brain, we differentiated SH-SY5Y human neuroblastoma cells
into functionally-matured DA neuronal phenotypes and found
that melatonin treatment increased PLC activity modestly but
significantly by more than 10% (p = 4.6 × 10–4). This increase
was entirely abolished by luzindole (p = 1.8 × 10–3) pointing to
the specific involvement of MT1 and MT2 (Figure 4A). Next,
we determined the effect of resveratrol on melatonin-dependent
PLC signaling and found that resveratrol (p = 1.0 × 10–3) had
a similar effect on PLC activity as luzindole (Figures 4A,B).
To probe for the role of SIRT1 in this resveratrol-dependent
effect, we applied sirt1-specific (SMO) and standard CMO
and confirmed their respective effect on SIRT protein levels
with western blots (Figure 4B). While melatonin-dependent
PLC activities were significantly reduced in the resveratrol
(p = 1.0 × 10–3) and resveratrol + CMO (p = 2.7 × 10–5)
groups, morpholino-dependent SIRT1 knockdown completely
rescuedmelatonin-dependent PLC activity close to original levels
(p = 0.32). These results suggest the involvement of SIRT1 in
melatonin-induced changes of PLC activity in SH-SY5Y cells.
DISCUSSION
SIRT1 is a protein deacetylase widely recognized for its
involvement in double-stranded DNA repair, chromosomal
stability and chronological aging in vertebrate and invertebrate
species (Blander and Guarente, 2004; Michan and Sinclair,
2007). SIRT1 also has gained considerable attention for its
role in regulating energy metabolism in response to dietary
changes, namely caloric restriction (Michan and Sinclair, 2007).
In mammals, SIRT1 is ubiquitously localized to the entire breath
of the central nervous system, including discrete anatomical
clusters generating circadian rhythms such as neurons of the
anterior hypothalamus (Zakhary et al., 2010). Among the
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FIGURE 4 | Increased gpr50 transcription decreases PLC activity in
SH-SY5Y cells with a matured dopamine neuronal phenotype. Two
ELISA fluorescence readout (λ516 nm) experiments with relevant groups were
performed. (A) Whereas melatonin treatment increases PLC activity from
baseline by about 10%, luzindole (selective MT1, MT2 antagonist) as well as
resveratrol completely reverses this effect. (B) Melatonin-mediated increases
in PLC activity are reversed by resveratrol while addition of standard control
morpholino mix (CMO) has no significant effect. The resveratrol-effect on PLC
activity is reversed by the addition of a SIRT1-specific morpholino (SMO) even
in the presence of resveratrol. SIRT1 protein levels (inset) are sensitive to SMO
but not CMO. Data are presented as the mean ± SEM. p < 0.05 by Student’s
t test for comparison with control (∗); n = 12 for all groups.
signaling cues that activate SIRT1-dependent signaling pathways,
at least in laboratory animals, is the regular consumption
of resveratrol (Baur and Sinclair, 2006; Torres et al., 2011).
These findings suggest that the brain is particularly sensitive to
bio-molecules that mimic physiological adaptations typical of
energy restriction, and also highlight the importance of SIRT1
in regulating key transcriptional steps in circadian oscillation.
Indeed, metazoan circadian rhythms are tightly coupled to
glucose metabolism and bioenergetics, including metabolic
pathways associated with the daily or seasonal activity of feeding
and fasting cycles (Mattson et al., 2014; Tasselli and Chua, 2015).
Our present findings provide further evidence on the
importance of SIRT1 in linking circadian rhythm components
and metabolic pathways both in vitro and in vivo experimental
conditions. Specifically, we show that SIRT1 directly associates
with the gene encoding gpr50 leading to its up-regulation
following the consumption of resveratrol during the rat’s
subjective night phase of the light-dark cycle. Although the
exact mechanism of this association needs yet to be described,
SIRT1 association with transcriptional complexes facilitating
FIGURE 5 | Schematic diagram depicts the effect of MT1/GPR50
heterodimer formation on PLC signaling events. Whereas MT1/MT1
G protein-coupled transmembrane homodimers are able to transduce
photoperiodic information via the activated α subunit of a trimeric (αβγ)
G protein Gαq to PLC, MT1/GPR50 heterodimers are unable to bind
melatonin and remaining inactive. The balance of active vs. inactive
transmembrane melatonin receptors is dependent on the transcriptional
activity of gpr50 governed by SIRT1 and resveratrol stimulus.
gene activation has been previously documented. For instance,
SIRT1 appears to interact with, and activate, transcription of
the peroxisome proliferator activated receptor-γ co-activator-
1α (PGC-1α) gene which controls overall metabolic function
(Amat et al., 2009). Along this theme, SIRT1 is known to
mediate transcriptional activation of neuroprotective pathways
preventing Huntington’s disease (Jeong et al., 2011). Another
line of evidence strengthening the connection between circadian
regulation and our current findings comes from work conducted
in GPR50 knockout mice. While GPR50 knockout animals do
not exhibit significant alterations in overall circadian periodicity,
their nocturnal and diurnal activity levels and metabolic rates are
significantly increased. A closer look at the knockout reporter
gene expression in place of gpr50 reveals a close link to the
cellular energy status (Ivanova et al., 2008) which falls in line with
the metabolic paradigm underlying the above resveratrol-SIRT1
association. Finally lack of gpr50 expression in the hypothalamus,
fails to respond to leptin and thyrotropin-releasing hormone
signals (Bechtold et al., 2012); hormone signals that are closely
intertwined in circadian rhythmicity and metabolic regulation,
respectively.
The transcriptional effect of the melatonin-related receptor
gene gpr50 is also seen in HEK293 human cells exposed
to doses of 50 µM resveratrol. These results, together with
the observed downstream effect on PLC activity, imply a
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functional relationship between SIRT1 and the melatonin
signaling machinery at the cellular as well at the organismal
level. Furthermore, the above results highlight the importance
of a resveratrol diet, mimicking calorie restriction, in coupling
SIRT1 with photoperiodic information, with the potential to
affect light-dark and sleep-wake cycles. In line with this notion,
resveratrol treatment obstructed the activity of intracellular
PLC often initiated by melatonin’s diffused signals in SH-
SY5Y human neuroblastoma cells. Both, homodimeric and
heterodimeric MT1/MT2 G protein-coupled receptor-agonist
complexes, activate PLC via the Gq protein to stimulate
the phosphoinositol second-messenger cascade, which in turn,
triggers the activation of protein kinase C and subsequent
steps (Ayoub et al., 2004; Jockers et al., 2008). For instance,
whereas MT2/GPR50 heterodimers are active participants
in melatonin signaling transduction, MT1/GPR50 complexes
appear to be inert, shifting overall PLC signaling to a less
active state in response to SIRT1-dependent transcriptional
regulation (Figure 5). This sequence of intracellular events is
thought to enable melatonin signals to synchronize synaptic
activity, circuit information and network connectivity to the
daily light-dark cycle (Pandi-Perumal et al., 2008; Baba et al.,
2013).
While light is the dominant timing cue for melatonin
circadian rhythm and for the entrainment of the SCN
oscillator in the anterior hypothalamus, our results suggest
that resveratrol consumption can also affect the activity of
transmembrane receptor-dependent melatonin signaling via
SIRT1 activity. As noted in the introductory paragraphs, SIRT1
is involved in the transcriptional activation of circadian rhythms,
particularly diurnal rhythms associated with food intake and
glucose metabolism (Mattson et al., 2014; Luna et al., 2015).
These observations clearly suggest that food consumption can
indirectly alter the melatonin-related receptor GPR50 and thus
likely shape unique network properties of the circadian clock in
the hypothalamus and/or peripheral tissues where the circadian
clock is cell-autonomous (Bechtold et al., 2012). In this context,
the GPR50 is implicated in adaptive thermogenesis and torpor in
rodents and in the pathophysiology of bipolar disorder andmajor
depression in women; brain disorders characterized by cognitive
and emotional dysregulation (Grünewald et al., 2012). These
observations suggest that specific components of foodstuffs can
profoundly alter brain function, supporting the notion that the
human brain may be particularly sensitive to changes in caloric
restriction and circadian timing of meals (Mattson et al., 2014).
In conclusion, our results support and extend the possibility
that a number of biomolecules and druggable brain targets may
be used to treat pathologies of the ailing brain. In the near future,
it is conceivable that brain disorders may require a broader
approach in which nutritional foodstuffs are essential in order to
provide better health outcomes, functioning and quality of life.
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